Long-term follow-up of patients treated with ICD: benefit in patients with preserved left ventricular function

Folke Rönn1, Milos Kesek, Niklas Höglund

  • 1Department of Cardiology, Heart Centre, Umeå University Hospital, Sweden.

Insights

Implantable cardioverter-defibrillators (ICDs) benefit patients with preserved heart function, offering life-saving therapy and good quality of life. Long-term outcomes show substantial survival benefits and low mortality in this population.

Area of Science:

  • Cardiology
  • Medical Devices
  • Clinical Trials

Background:

  • Major defibrillator trials often have limited follow-up periods.
  • This limits understanding of long-term benefits in patients with preserved ejection fraction and advanced heart disease progression.

Purpose of the Study:

  • To investigate the long-term outcomes of implantable cardioverter-defibrillators (ICDs) in an unselected patient population.
  • To evaluate the effectiveness and safety of ICDs over an extended follow-up period.

Main Methods:

  • A cohort of 124 consecutive patients receiving an ICD between 1993-2002 was followed for a median of 6.1 years.
  • Data on heart disease, index arrhythmia, follow-up, and mortality were retrospectively collected from medical records.

Main Results:

  • Crude mortality was 26% over the follow-up period.
  • Heart failure was the primary cause of death (75%), particularly in patients with ejection fraction <35% (91% of deaths).
  • An estimated 28% of patients received life-saving ICD therapy, with no significant relation between saved lives/complications and ejection fraction.

Conclusions:

  • Implantable cardioverter-defibrillators (ICDs) are highly beneficial for patients with preserved left ventricular function.
  • These patients experience substantial life-saving therapies, low mortality rates, and maintain a good quality of life.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...